Alector Inc (NASDAQ:ALEC) Director Orbimed Advisors Llc purchased 411,700 shares of the firm’s stock in a transaction that occurred on Monday, February 11th. The shares were bought at an average price of $19.00 per share, with a total value of $7,822,300.00. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Shares of Alector stock opened at $17.50 on Wednesday.
ILLEGAL ACTIVITY NOTICE: This story was first published by Markets Daily and is owned by of Markets Daily. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.themarketsdaily.com/2019/02/13/orbimed-advisors-llc-purchases-411700-shares-of-alector-inc-alec-stock.html.
Alector, Inc, a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease.
Read More: Stop Order Uses For Individual Investors
Receive News & Ratings for Alector Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alector and related companies with MarketBeat.com's FREE daily email newsletter.